ASMA Eventos serios en asma con fluticasona/salmeterol en comparación con fluticasona: Estudio AUSTRI

Iván Solarte Rodríguez, MD., Manuela Tobón Trujillo, MD.

Texto completo:

PDF

Referencias


Ernst P, Habbick B, Suissa S, et al. Is the association between inhaled beta agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis. 1993;148:75-9.

Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonist and the risk of death and near death from asthma. N Engl J Med. 1992;326:501-6.

CastleW, FullerR, Hall J, Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bornchodilator treatment. BMJ 1993;306:1034-7.

Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. The Salmeterol Multicenter Asthma research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006;129:15-26.

Weatherall M, Wijesinghe M, Perrin K, Harwood M, Beasley R. Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax 2010;65:39-43.

Salpeter SR. An update on the safety of long-acting beta agonists in asthma patients using inhaled corticosteroids. Exper Opin Drug Saf. 2010;9:407-19.




DOI: http://dx.doi.org/10.30789/rcneumologia.v27.n3.2015.92

Métricas de artículo

Vistas de resumen
149




Cargando métricas ...

Enlaces refback

  • No hay ningún enlace refback.


Asociación Colombiana de Neumología y Cirugía de Tórax.
Dirección: Carrera 7 Bis # 123-52 Of. 202, Teléfono: 57(1)3222335 - Bogotá - Colombia.
Sistema OJS - Metabiblioteca |